Ligand Information
| Ligand General Information | Top | |||
|---|---|---|---|---|
| Ligand ID |
L0F7XJ
|
|||
| Ligand Name |
Camptothecin sodium
|
|||
| Synonyms |
9EXB349FJ9; 34079-22-6; Camptothecin sodium; Camptothecine sodium; Na-Cpt; INDOLIZINO(1,2-B)QUINOLINE-7-ACETIC ACID, .ALPHA.-ETHYL-9,11-DIHYDRO-.ALPHA.-HYDROXY-8-(HYDROXYMETHYL)-9-OXO-, (.ALPHA.S)-; Indolizino[1,2-b]quinoline-7-acetic acid, .alpha.-ethyl-9,11-dihydro-.alpha.-hydroxy-8-(hydroxymethyl)-9-oxo-, (.alpha.S)-; FDA 1660; NSC100880; CAMPTOTHECINIC ACID; 25387-67-1; NCIStruc1_001533; NCIStruc2_001158; Camptothecin carboxylate form; UNII-9EXB349FJ9; CHEMBL1205903; SCHEMBL12717183; CAMPTOTHECINE HYDROXY ACID; DTXSID70187675; ZINC3954245; (2S)-2-hydroxy-2-[8-(hydroxymethyl)-9-oxo-11H-indolizino[1,2-b]quinolin-7-yl]butanoic acid; 21,22-SECOCAMPTOTHECIN-21-OIC ACID; Q27459945; (.ALPHA.S)-.ALPHA.-ETHYL-9,11-DIHYDRO-.ALPHA.-HYDROXY-8-(HYDROXYMETHYL)-9-OXOINDOLIZINO(1,2-B)QUINOLINE-7-ACETIC ACID; INDOLIZINO(1,2-B)QUINOLINE-7-ACETIC ACID, .ALPHA.-ETHYL-9,11-DIHYDRO-.ALPHA.-HYDROXY-8-(HYDROXYMETHYL)-9-OXO-, (S)-; Indolizino(1,2-b)quinoline-7-acetic acid, alpha-ethyl-9,11-dihydro-alpha-hydroxy-8-(hydroxymethyl)-9-oxo-, (S)-
Click to Show/Hide
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H18N2O5
|
|||
| Canonical SMILES |
CCC(C1=C(C(=O)N2CC3=CC4=CC=CC=C4N=C3C2=C1)CO)(C(=O)O)O
|
|||
| InChI |
1S/C20H18N2O5/c1-2-20(27,19(25)26)14-8-16-17-12(9-22(16)18(24)13(14)10-23)7-11-5-3-4-6-15(11)21-17/h3-8,23,27H,2,9-10H2,1H3,(H,25,26)/t20-/m0/s1
|
|||
| InChIKey |
SARNOWGPKQIWFT-FQEVSTJZSA-N
|
|||
| PubChem Compound ID | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.